| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3189405 | Annales de Dermatologie et de Vénéréologie | 2008 | 4 Pages |
Abstract
Allopurinol was stopped definitively because of its more frequent imputability. Imatinib was reintroduced after considering the benefit-risk ratio and in full knowledge of the existence of cutaneous reactions to imatinib, despite there being only one recent report of DRESS following treatment with imatinib. According to the causality criteria of Bégaud et al. regarding imatinib, inherent causality of the drug in our patient was initially possible (I2) and appeared likely (I3) after the rechallenge test. This case clearly illustrates that imatinib is a potential cause of DRESS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
J. Goldman, A.-B. Duval-Modeste, A. Lambert, N. Contentin, P. Courville, P. Musette, P. Joly,